Cargando…
Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and suppor...
Autores principales: | Arnet, Isabelle, Verbeek, Melina, Almarsdóttir Anna, Birna, Barbier, Liese, Clifford, Rhonda, Eickhoff, Christiane, Hersberger, Kurt, Huys, Isabelle, Lee, Kenny, Saramunee, Kritsanee, Schulz, Martin, Zgarrick, David, Sarnola, Kati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032461/ https://www.ncbi.nlm.nih.gov/pubmed/35479848 http://dx.doi.org/10.1016/j.rcsop.2021.100084 |
Ejemplares similares
-
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
por: Barbier, Liese, et al.
Publicado: (2020) -
European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice
por: Barbier, Liese, et al.
Publicado: (2020) -
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019) -
Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking
por: Barbier, Liese, et al.
Publicado: (2022) -
“Biosimilar, so it looks alike, but what does it mean?” A qualitative study of Danish patients' perceptions of biosimilars
por: Varma, Meera, et al.
Publicado: (2022)